Correlation Between Commonwealth Global and Franklin Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Commonwealth Global and Franklin Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Commonwealth Global and Franklin Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Commonwealth Global Fund and Franklin Biotechnology Discovery, you can compare the effects of market volatilities on Commonwealth Global and Franklin Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Commonwealth Global with a short position of Franklin Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Commonwealth Global and Franklin Biotechnology.

Diversification Opportunities for Commonwealth Global and Franklin Biotechnology

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between Commonwealth and Franklin is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Commonwealth Global Fund and Franklin Biotechnology Discove in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Biotechnology and Commonwealth Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Commonwealth Global Fund are associated (or correlated) with Franklin Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Biotechnology has no effect on the direction of Commonwealth Global i.e., Commonwealth Global and Franklin Biotechnology go up and down completely randomly.

Pair Corralation between Commonwealth Global and Franklin Biotechnology

Assuming the 90 days horizon Commonwealth Global Fund is expected to generate 0.46 times more return on investment than Franklin Biotechnology. However, Commonwealth Global Fund is 2.19 times less risky than Franklin Biotechnology. It trades about 0.29 of its potential returns per unit of risk. Franklin Biotechnology Discovery is currently generating about -0.06 per unit of risk. If you would invest  2,081  in Commonwealth Global Fund on September 1, 2024 and sell it today you would earn a total of  91.00  from holding Commonwealth Global Fund or generate 4.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Commonwealth Global Fund  vs.  Franklin Biotechnology Discove

 Performance 
       Timeline  
Commonwealth Global 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Commonwealth Global Fund are ranked lower than 3 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong essential indicators, Commonwealth Global is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Franklin Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Franklin Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Commonwealth Global and Franklin Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Commonwealth Global and Franklin Biotechnology

The main advantage of trading using opposite Commonwealth Global and Franklin Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Commonwealth Global position performs unexpectedly, Franklin Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Biotechnology will offset losses from the drop in Franklin Biotechnology's long position.
The idea behind Commonwealth Global Fund and Franklin Biotechnology Discovery pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal